Status:
COMPLETED
Supporting Self-Management of Healthy Behaviors in Chronic Kidney Disease
Lead Sponsor:
University of Pennsylvania
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Renal Insufficiency, Chronic
Hypertension
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The pilot cross-over study aims to examine the feasibility of a smartphone-based self-management supportive intervention, Supporting Self-Management of Healthy Behaviors (SMART-HABITS) in patients wit...
Detailed Description
The pilot study aims to examine the feasibility, as measured by adoption, adherence, and acceptance, of a smartphone-based self-management supportive intervention, Supporting Self-Management of Health...
Eligibility Criteria
Inclusion
- adult patients with hypertension (treated with three or less anti-hypertensive medications) and chronic kidney disease stage 3 or 4 managed in participating nephrology practices
- have a smartphone that they are willing to carry with them the majority of the time while enrolled in the study
- able to comprehend English,
- have ability to walk.
- mean blood pressure of \<=180/100 mmHg from historical blood pressure readings in the electronic medical record
- able and willing to provide informed consent
Exclusion
- inability to provide consent or read or speak English
- had MI or stroke within the previous six months,
- diagnosis of dementia or cognitive impairment
- inability to walk
- already participating in another physical activity study
- belong to vulnerable population
- likely to receive a kidney transplant within 1 month of enrollment into the trial
- living in a long-term care or rehabilitation institution
- likely to have their care transferred to another facility outside participating clinic areas during the course of the study
- planning to travel or live consecutively out of the country for more than one month
- participating in another intervention trial,
- hypertension not managed by the nephrologist in the clinic
- prescribed more than three anti-hypertensive medications (i.e. resistant hypertension),
- any other reason they do not expect to be able to complete the study.
Key Trial Info
Start Date :
July 26 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2023
Estimated Enrollment :
47 Patients enrolled
Trial Details
Trial ID
NCT04858295
Start Date
July 26 2021
End Date
May 1 2023
Last Update
November 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania, United States, 19104